ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Unraveling metabolic dependencies in childhood supratentorial ependymomas.||Regents of the University of Michigan / Sriram Venneti, MD/PhD||Innovation Grants||2021||Michigan|
|Hematopoietic stem cell function in familial platelet disorder therapy||University of Massachusetts Medical School / Lucio Castilla, PhD||Innovation Grants||2021||Massachusetts|
|GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma||Board of Trustees of the Leland Stanford Junior University / Michelle Monje||Catalyst Grants||2021||California|
|Targeting EZHIP as a therapeutic strategy for infantile ependymomas||University of Wisconsin - Madison / Peter Lewis, PhD||Innovation Grants||2021||Wisconsin|
|Novel targeting approach for pediatric B-cell malignancies||Thomas Jefferson University / Christine Eischen, PhD||Innovation Grants||2021||Pennsylvania|
|Novel Genomic Diagnostics for Intracranial Germ Cell Tumors||Connecticut Children's Medical Center Foundation, Inc. / Ching Lau, MD/PhD||Reach Grants||2021||Connecticut|
|Dual PTK7/GD2 Gamma Delta CAR T Cell Therapy for Neuroblastoma||Emory University / Kelly Goldsmith, MD & H. Trent Spencer, PhD & Chris B. Doering, PhD||Reach Grants||2021||Georgia|
|Stapled Peptide PROTAC: A 3-in-1 Treatment for Pediatric Solid Tumors||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Reach Grants||2021||Massachusetts|
|Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG||Mayo Clinic / David Daniels, MD/PhD||Reach Grants||2021||Minnesota|
|IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas||Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD||Reach Grants||2021||New York|